Trial
NCT04725110
Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Minnesota
Collaborators
—
Condition
Covid19
Intervention
Instilled T3
Why stopped
Duplicate record to NCT04115514
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-10